NCT02013687View on ClinicalTrials.gov

Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

January 31, 2015

Conditions
Malaria
Interventions
BIOLOGICAL

Pfs25 VLP- FhCMB

Trial Locations (1)

20850

Accelovance, Rockville

All Listed Sponsors
lead

Fraunhofer, Center for Molecular Biotechnology

INDUSTRY

NCT02013687 - Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults | Biotech Hunter | Biotech Hunter